
The pill hasn't been improved in years. No wonder women are giving up on it
Something is changing when it comes to contraception. Lots of people aren't using it. Last week we heard that this includes a third of young Irish people. Meanwhile, there has been a significant rise in abortions in England and Wales. Prescriptions for the contraceptive pill in England dropped from 432,600 in 2014 to 188,500 in 2021. And this month data from abortion clinics found that demand is being fuelled by women coming off the pill and using natural methods instead.
When the study compared contraception used by women seeking abortions in 2018 and in 2023, it found that the proportion using smartphones to track their menstrual cycle had increased from 0.4% to 2.5%. The use of hormonal contraception among this group fell from 19% to 11%, while the group not using any form of contraception when they became pregnant increased from 50% to 70%.
Why? When it comes to the declining popularity of birth control, two factors are at play. One is a conservative backlash against it, starting in America. Alex Clark, a pro-Trump media personality, has called the birth control pill 'poison' and said it will cause 'issues with fertility' later in life. She has even suggested it can 'falsely make women feel bisexual' – claims that are all untrue. And conservative commentator Candace Owens has denounced the pill and intrauterine devices as 'unnatural'. Elon Musk has tweeted that hormonal birth control 'makes you fat, doubles risk of depression & triples risk of suicide'.
Colliding with this is the wellness movement, which has a history of advising people to treat themselves with 'natural' rather than medically proven methods. As the media landscape splinters, individual voices gain power to persuade. Videos on TikTok and Instagram, many exaggerating the side-effects of the pill, gain millions of views. Then there are individual bad experiences that may gain disproportionate attention, giving the impression that birth control is more dangerous than it is.
Public health leaders are trying to combat these forces – the NHS has warned that misinformation about the pill on social media, especially a false claim that it causes infertility, is putting women off. But there's another, underlying problem when it comes to contraception: it needs to improve.
Many are deeply dissatisfied with the contraceptives we have. Bad information aside, condoms fail, IUDs are invasive and can be painful to implant, hormonal methods have side-effects such as headaches, weight gain, acne and depression. Of women who take the contraceptive pill, about a third stop in the first year, many due to health concerns and worries about side-effects.
The cultural battle over contraception is largely focused on whether people should abandon existing methods, or whether that is irresponsible advice. But there's another question we should be asking. It's common for women to be using the same methods as their mothers – or even their grandmothers. Why aren't contraceptives getting better?
There is certainly appetite for new ideas. New products are often greeted with excitement: when Lo Loestrin, a hormonal pill with lower oestrogen, was introduced in 2011, it quickly became popular. But, oddly, there seems to be little appetite for developing it. Research has centred on small improvements to existing contraceptives. There were just 20-25 industry-funded clinical trials between 2017 and 2020, compared with 600 for cardiovascular drugs in 2019 alone. While pharmaceutical companies tend to plough 20% of their sales revenue back into research and development, for contraception it is 2%. Funding is limited, propped up by the public sector.
Why isn't more work being done to improve contraceptives? Part of the problem is that when you give a drug to a healthy population, the safety requirements and litigation risks are higher, which may put investors off. Worldwide, the contraceptive market is still growing, despite dissatisfaction; many women are just accepting the trade-offs. This means there has been no big market signal that things need to change.
But the history of contraception reflects the culture at large. While conservative forces are trying to push women off the pill by claiming it is dangerous, it was they who stymied research in the first place. Underlying this, too, is an expectation that women will put up with significant side-effects. As long as contraceptives work, unhappiness is ignored or underplayed.
There is hope on the horizon. While women's contraceptives have stagnated, a new range of imaginative treatments is on the way – for men. One, for example, is a gel that works to block fertility when smeared on the arms and shoulders, without affecting mood or libido.
Sign up to Observed
Analysis and opinion on the week's news and culture brought to you by the best Observer writers
after newsletter promotion
While female side-effects are considered acceptable, given they are weighed against the risks of pregnancy, researchers conducting trials do not think men would accept the same bargain. In 2011, a male contraceptive trial was halted when it emerged that side-effects included mood swings and depression – commonly experienced by women on the pill.
Nevertheless, the arrival of better contraception for men could make things easier for their female partners who don't like the options available. Innovations for men could also cross over into solutions for women, as the bar for safety and effectiveness is raised.
There is the risk, too, that, as male contraceptives suck up airtime and funding, women's will continue to fall behind: almost half of pregnancies around the world are unintended – a high proportion of them in places where birth control is accessible. The need for change is urgent.
Martha Gill is an Observer columnist

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mail
an hour ago
- Daily Mail
EXCLUSIVE Biden White House doctor accused of disgusting act on the job... as he braces for Congress grilling over health cover-up
Vicious accusations are flying among three former White House doctors, as President Joe Biden 's personal physician is set to be hauled in front of . On Tuesday, ex-Trump White House doctor turned Republican congressman Ronny Jackson told the Daily Mail that former Biden doctor, Dr Kevin O'Connor, engaged in shockingly bizarre and sexually inappropriate behavior in the White House.


The Guardian
4 hours ago
- The Guardian
Loss of data relating to inquiry at NHS trust most likely deliberate, say police
A missing data file containing the details of hundreds of maternity cases was most likely deleted 'intentionally or maliciously', a police investigation has concluded. Nottinghamshire police began an investigation in February into the temporary loss of the computer file at Nottingham University Hospitals (NUH) NHS trust. The trust is at the centre of the largest maternity inquiry in the history of the NHS, examining deaths and harm spanning more than a decade at the Queen's Medical Centre and Nottingham city hospital. The police force's cyber team said the deletion was 'most likely to be the action of an individual' but the loss 'was not caused or contributed to by any systemic corruption within NUH'. A letter to families involved in the inquiry, seen by the BBC, from assistant chief constable Rob Griffin said the deletion was 'most likely to have been done intentionally/maliciously rather than accidentally'. Police said the identity of the culprit could not be determined. The trust previously said the computer file went missing in July 2024 for a few days. It was recovered after its deletion was spotted by the trust and led to about 300 more cases being added to the maternity inquiry. Nearly 2,500 cases are being examined by the senior midwife, Donna Ockenden, and a national team of leading doctors and midwives, whose review is due to conclude in summer 2026. A statement from the Nottingham Affected Families Group said: 'Nottingham families would like to thank the police for their determined investigation. We are distressed that they were unable to find who did this. 'We are appalled to hear this news, though sadly we are not surprised … To know that there is most likely an individual who is capable of such behaviour is devastating for the already harmed and for the future of NUH safety. 'We call for openness at this worrying time and for the individual, their colleagues or anyone who knows anything about this to come forwards as a matter of urgency. This is a patient safety emergency.' Anthony May, chief executive of NUH, said: 'I would like to thank Nottinghamshire police for their support in investigating this matter and we accept their findings. Upon discovering the issue, the trust informed Nottinghamshire police and engaged fully in the investigation. 'We have put appropriate measures in place to secure digital files so that this cannot happen again.' Last week, Nottinghamshire police said they were investigating possible corporate manslaughter at the trust over the deaths and severe harm of more than 2,000 babies and women. Det Supt Matthew Croome said at the time that the alleged offences related to 'circumstances where an organisation has been grossly negligent in the management of its activities, which has then led to a person's death'.


The Independent
4 hours ago
- The Independent
New NHS guidelines mean younger women could have fewer cervical screenings
Women aged 25 to 49 who test negative for human papillomavirus (HPV) will be invited to cervical screening every five years instead of every three, under new NHS guidelines. The change, set to take effect next month in England, follows recommendations from the UK National Screening Committee. According to analysis from King's College London, extending the screening interval to five years for HPV-negative women is just as safe as the current three-year interval, with a similar rate of cancer detection. HPV is a sexually transmitted group of viruses, with around 13 high-risk types known to cause almost all cases of cervical cancer. Most people with HPV don't experience any symptoms. Women who test positive for HPV, or have a history of the virus, will continue to be invited for more frequent screenings to monitor the virus and check for any changes to cells in the cervix. In a written statement to Parliament, health minister Ashley Dalton said the new change 'increases the opportunities to test and recall women and people with a cervix who have HPV, while extending the cervical screening intervals from three to five years in England for individuals who have a negative HPV test. 'This will bring England's cervical screening intervals in line with those of Wales and Scotland.' She said the NHS screening programme in England provides all women between the ages of 25 and 64 'with the opportunity to be screened routinely to detect HPV infection or cervical abnormalities at an early, more treatable stage'. She added: 'The aim of the programme is to reduce the number of women who develop invasive cervical cancer and reduce the number who die from it.' Ms Dalton said testing negative for HPV means the chances of developing cancer within five years are very small, as it can take around 10 years or more from the time HPV is detected to developing cervical cancer. She added: 'Those who test positive for HPV are already being followed up with yearly testing. 'This is important to ensure that individuals are monitored for any early signs of cervical abnormalities and provided the necessary treatment.' Experts have been concerned about falling numbers of women under 50 attending cervical screening, with around a third in England not taking up their invitations. Dr Sue Mann, NHS national clinical director for women's health, said: 'Taking a more personalised approach to cervical screening will help ensure everyone eligible can make the most of these life-saving services, while sparing women appointments that they don't need. 'The NHS is following robust evidence on how often women need to be safely screened, and by putting invitations and reminders straight in women's pockets on their phones, we're making it easier than ever to take up screening appointments. 'Make sure you come forward for your screening when you're invited, even if it was weeks, months or years ago. If you think you are due but have not yet had an invitation, speak to your GP practice.' Michelle Mitchell, chief executive of Cancer Research UK, said: 'We welcome this change to cervical screening in England, which is the result of years of vital research to make screening more effective and has shown it is safe to extend the time between tests. 'Screening, alongside the roll out of the HPV vaccine – which Cancer Research UK scientists helped develop – have seen cervical cancer rates drop by around a quarter since the early 1990s, and we look forward to even more progress. 'If you notice any unusual changes for you, do not wait for a screening invitation – speak to your doctor.' Athena Lamnisos, chief executive of the Eve Appeal, said: 'We want every eligible person to feel empowered to attend a vaccination and cervical screening appointment when they are invited so we can achieve the brilliant ambition of eliminating cervical cancer.'